Dengvaxia Controversy
| Use attributes for filter ! | |
| Deaths | 142 people (139 children and 3 adults) (as of July 4, 2019) |
|---|---|
| Date of Reg. | |
| Date of Upd. | |
| ID | 950980 |
About Dengvaxia Controversy
The Philippine Department of Health, in late November 2017, temporarily suspended a school-based dengue vaccination program after French drug based vaccine maker Sanofi Pasteur made a statement that its product poses higher risks to people without prior dengue infection.
